Bench Mark Infotech Services IPO Day 4: GMP ₹12

Welcome back to our daily deep dive into the Bench Mark Infotech Services SME IPO! We’re now at the crucial Day 4 of its subscription period, which runs from September 25th to September 29th, 2026. As the clock ticks down, investors are keen to see how the market is responding to this offering priced at ₹110 per share. Today, we’ll break down the subscription numbers and the Grey Market Premium (GMP) to help you make an informed decision.

Subscription Status

As we enter Day 4, the subscription numbers for Bench Mark Infotech Services IPO stand at a rather subdued 0x across all categories: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This is a significant point to consider. Typically, by Day 4, we’d expect to see at least some level of oversubscription, especially in the Retail segment, given it’s an SME IPO often targeted by smaller investors. The complete lack of subscription across the board, even at this late stage, could concern potential investors. It might indicate a cautious market sentiment towards this particular issue, or perhaps investors are waiting for a last-minute surge, which is less common for SME IPOs. The lot size is 1200 shares, so even a single subscription would show a number greater than zero. The absence of any figures here means no applications have been formally registered yet.

GMP Update

Interestingly, the Grey Market Premium (GMP) for Bench Mark Infotech Services IPO has remained steady at ₹12. This is the same as yesterday’s figure. The GMP is a good, albeit unofficial, indicator of market demand and expected listing gains. A ₹12 GMP on an issue price of ₹110 suggests an expected listing price of around ₹122 (Issue Price + GMP). While a positive GMP is always encouraging, a stagnant one, especially when subscription numbers are non-existent, might not be enough to create significant buzz. It tells us that the market sentiment, as reflected by unofficial traders, hasn’t shifted. It’s not a red flag, but it’s certainly not a strong signal of overwhelming demand either.

Should You Apply?

So, the million-dollar question: should you apply for the Bench Mark Infotech Services IPO? Let’s weigh the facts. On one hand, the GMP is positive, suggesting a potential listing gain. The expected listing price of ₹122 per share offers a decent premium over the issue price of ₹110. However, the subscription numbers are the elephant in the room. The complete lack of subscriptions on Day 4 is unusual and warrants caution. It’s essential to remember that SEBI advisors strongly recommend thorough research before investing. While the GMP provides a glimpse, it’s not a substitute for understanding the company’s fundamentals, its business model, and its future prospects. The current subscription data doesn’t paint a picture of high demand, and a stagnant GMP further reinforces this observation. Investors might want to wait until the final day to see if there’s a last-minute rush, or perhaps look for other opportunities if this trend continues. The bottom line is, while the potential for listing gains exists, the muted subscription activity suggests a need for a more cautious approach.

View Full Bench Mark Infotech Services IPO Details